FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

77544001: Nicotine polacrilex (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
128721017 Nicotine polacrilex en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
818386018 Nicotine polacrilex (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4454471000005113 nicotin-polacrilex da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nicotine polacrilex Is a Product containing nicotine (medicinal product) false Inferred relationship Some
Nicotine polacrilex Is a Nicotine false Inferred relationship Some
Nicotine polacrilex Is a nicotinmiddel false Inferred relationship Some
Nicotine polacrilex This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Nicotinic receptor agonist (disposition) true Inferred relationship Some
Nicotine polacrilex This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that is produced by a living organism and is toxic, noxious, or poisonous. true Inferred relationship Some
Nicotine polacrilex Is a Plant alkaloid true Inferred relationship Some
Nicotine polacrilex Is a Drug allergen false Inferred relationship Some
Nicotine polacrilex Is a Psychoactive substance (substance) true Inferred relationship Some
Nicotine polacrilex Is a Phytotoxin true Inferred relationship Some
Nicotine polacrilex Is a Nicotinic receptor agonist true Inferred relationship Some
Nicotine polacrilex This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Nicotine true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Nicotine (as nicotine polacrilex) 2 mg oral gum chewing gum The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotine polacrilex Inferred relationship Some 1
Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotine polacrilex Inferred relationship Some 1
Product containing precisely nicotine (as nicotine polacrilex) 4 milligram/1 chewing gum prolonged-release oral gum (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotine polacrilex Inferred relationship Some 1
Product containing precisely nicotine (as nicotine polacrilex) 1 milligram/1 each conventional release oromucosal lozenge (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotine polacrilex Inferred relationship Some 1
Nicotine (as nicotine polacrilex) 4 mg oromucosal lozenge The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotine polacrilex Inferred relationship Some 1
Nicotine (as nicotine polacrilex) 1.5 mg oromucosal lozenge The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nicotine polacrilex Inferred relationship Some 1
Nicotine chewing gum The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Nicotine polacrilex Inferred relationship Some 1
Nicotine chewing gum The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Nicotine polacrilex Inferred relationship Some 1

This concept is not in any reference sets

Back to Start